Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting
PRESS RELEASE Magnitude of EO2463-induced CD8 T-cell expansion during monotherapy statistically significantly…
OMEICOS OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA
Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of…
Carbios reaches milestone of 100 batches at its Industrial demonstration plant and expands its licensing offering to the textile market
Validation of the "Fiber-to-Fiber" biorecycling process under conditions representative of industrial operations100th…
Helport AI Completes Key Consumer Finance AI Labor Workflow, Advancing Toward Scalable Replication
SAN DIEGO and SINGAPORE, July 20, 2026 (GLOBE NEWSWIRE) -- Helport AI…
Gatekeeper Unveils New Visual Identity to Reflect Its Natively Unified Architecture and Agentic Innovation
Now with full MCP support across every frontier LLM and a new…
CMG Announces Date for First Quarter 2027 Results and Conference Call
CALGARY, Alberta, July 20, 2026 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd.…
VERAXA Biotech Announces Regulatory Progress with its BiTAC-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA;…
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO and BYOOVIZ at ASRS 2026 Annual Meeting
July 20, 2026 07:00 ET | Source: Harrow, Inc. NASHVILLE, Tenn., July…
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
July 20, 2026 07:00 ET | Source: Kamada Ltd. REHOVOT, Israel and…
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
July 18, 2026 15:15 ET | Source: 4D Molecular Therapeutics, Inc. After…
